PP_1170x120_10-25-21

AllianceRx Walgreens Prime

WBA’s Q4 earnings top analysts’ forecast

WBA’s Q4 earnings top analysts’ forecast

DEERFIELD, Ill. — Walgreens Boots Alliance (WBA) beat Wall Street’s adjusted earnings per share forecast for its 2017 fourth quarter and fiscal year, with pharmacy results helping boost sales for both periods. However, WBA said Wednesday that costs related to the unsuccessful deal to acquire Rite Aid Corp. impacted its bottom line and pulled down

AllianceRx Walgreens Prime up and running

AllianceRx Walgreens Prime up and running

ORLANDO, Fla. — Merging the specialty pharmacy and mail service capabilities of Walgreens and Prime Therapeutics LLC has created a whole that is greater than the sum of its parts, says Joel Wright, chief executive officer of the newly formed AllianceRx Walgreens Prime. Increased purchasing scale and the addition of Prime’s clinical and lives management

AllianceRx Walgreens Prime brand makes debut

AllianceRx Walgreens Prime brand makes debut

ORLANDO, Fla. — Walgreens and Prime Therapeutics LLC have inaugurated AllianceRx Walgreens Prime, the brand for the joint central specialty pharmacy and mail services company they formed earlier this year. The companies said the AllianceRx Walgreens Prime launch included the unveiling of new signage at its headquarters in Orlando, Fla., and at other company-owned facilities

WBA, Prime Therapeutics tab leaders for joint venture

DEERFIELD, Ill. — Walgreens Boots Alliance Inc. (WBA) and Prime Therapeutics LLC have completed the formation of a combined central specialty pharmacy and mail service company, a move that was first announced last August. The leadership team of the new enterprise, AllianceRx Walgreens Prime, has also been ­revealed. Joel Wright, formerly divisional vice president for

BCBS specialty Rx FEP contract to shift from CVS to Prime

BCBS specialty Rx FEP contract to shift from CVS to Prime

NEW YORK — Next year, the specialty pharmacy services contract for the Blue Cross and Blue Shield Federal Employee Program (FEP) is slated to pass from CVS Health to Prime Therapeutics LLC. CVS said its specialty pharmacy contract with BCBS FEP will terminate at the end of 2017. Under separate agreements that run through 2018,

Walgreens, Prime Therapeutics launch company

Walgreens, Prime Therapeutics launch company

DEERFIELD, Ill., and ST. PAUL, Minn. — Walgreens and pharmacy benefit manager Prime Therapeutics LLC have completed their transaction to form a joint pharmacy services company and announced its leadership. Called AllianceRx Walgreens Prime and based in Orlando, Fla., the new company melds the central specialty pharmacy and mail service businesses of Walgreens and Prime